Five lines of inquiry
Our editorial focus follows the same thesis as our work: where AI-speed safety data meets the human, documented judgment regulators require.
Advanced Oncology Safety
CAR-T (CRS/ICANS), ADC organ toxicity, radioligand dosimetry, and the AMOIP window — why advanced therapeutics break legacy pharmacovigilance.
RegulatoryRTCT & Regulatory
The FDA's Real-Time Clinical Trials initiative, inspection expectations for AI-assisted safety, and what regulators are signalling in plain language.
TechnologyCompliant AI & Platform
Physician-in-the-loop architecture, 21 CFR Part 11 in the age of AI, and the road to a unified, compliant safety platform.
OperationsClinical Operations
Medical monitoring, ICU-aligned safety governance, and proactive oversight across pediatric, adult, and elderly populations.
PlatformeClinical Technology
Lessons from building the industry's first unified EDC + RTSM + eCOA + Safety platform across 1,000+ trials.
EverythingAll articles & news
Browse the full feed, including press and event coverage. →
Start here
Latest insights
Upcoming events & training
From reading to readiness
If a briefing here describes a gap in your own program, the Readiness Assessment is the fastest way to grade it — 3–4 weeks, fixed fee, a roadmap you own.
Book a Readiness Assessment